Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Johnson & Johnson and every other company we cover.
Try it first on NVDA, AAPL, META or NKE, where it is open to everyone.
JNJ · NYSE · ·
Next earnings: October 13, 2026 · before the open
$267.55-1.6%Sep 29 close
Makes prescription medicines and medical devices for cancer, immune disorders, surgery, heart care, joint replacement and vision.